Hardik Ghelani

Pharmacological interventions on dyslipidaemia of nephrotic syndrome and chronic kidney disease: A mechanistic approach

Chronic kidney disease (CKD) is reaching epidemic proportions worldwide. Cases of CKD are expected to climb rapidly, posing a significant risk of cardiovascular diseases. Hardik's project will investigate the effectiveness of various natural products such as α-lipoic acid, ginger extract and curcumin on restoring the deranged lipid metabolism in CKD. This may result in health improvements as well as prolonging the lives of those affected with nephrosis and CKD. Hardik's project has the potential to reduce private and public healthcare costs and to promote and maintain good health and healthy ageing.

Hardik obtained both his Bachelor and Master's degrees in Pharmacy in India. In 2015, he completed a Master's of Science (Research) degree from Western Sydney University. Hardik presents extensive research experience in the areas of pharmacology, physiology and experimental techniques involved in the pharmacological screening of new herbal drugs. His research areas include the evaluation and identification of mechanism(s) of action of traditional herbal medicines in the treatment/prevention of obesity, type 2 diabetes and its complications, lipid disorders and cardiovascular diseases.


Dr Srinivas Nammi, Dr Valentina Naumovski, Professor Dennis Chang